Search Results - "Vetro, Joseph A"

Refine Results
  1. 1

    Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles by Braun, Chad S, Vetro, Joseph A, Tomalia, Donald A, Koe, Gary S, Koe, Janet G, Middaugh, C Russell

    Published in Journal of pharmaceutical sciences (01-02-2005)
    “…PAMAM dendrimers are members of a class of polyamine polymers that demonstrate significant gene delivery ability. In this study, a selection of PAMAM…”
    Get more information
    Journal Article
  2. 2

    Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant by Karuturi, Bala Vamsi K, Tallapaka, Shailendra B, Phillips, Joy A, Sanderson, Sam D, Vetro, Joseph A

    Published in Clinical immunology (Orlando, Fla.) (01-12-2015)
    “…Abstract EP67 is a complement component 5a (C5a)-derived peptide agonist of the C5a receptor (CD88) that selectively activates DCs over neutrophils. Systemic…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Direct Comparison of Chol-siRNA Polyplexes and Chol-DsiRNA Polyplexes Targeting STAT3 in a Syngeneic Murine Model of TNBC by Ye, Zhen, Abdelmoaty, Mai Mohamed, Curran, Stephen M, Dyavar, Shetty Ravi, Kumar, Devendra, Alnouti, Yazen, Coulter, Don W, Podany, Anthony T, Singh, Rakesh K, Vetro, Joseph A

    Published in Non-coding RNA (13-01-2022)
    “…RNA interference (RNAi) molecules have tremendous potential for cancer therapy but are limited by insufficient potency after intravenous (IV) administration…”
    Get full text
    Journal Article
  5. 5

    Yeast methionine aminopeptidase type 1 is ribosome-associated and requires its N-terminal zinc finger domain for normal function in vivo by Vetro, Joseph A., Chang, Yie-Hwa

    Published in Journal of cellular biochemistry (2002)
    “…Methionine aminopeptidase type 1 (MetAP1) cotranslationally removes N‐terminal methionine from nascent polypeptides, when the second residue in the primary…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancer by Ye, Zhen, Abdelmoaty, Mai Mohamed, Ambardekar, Vishakha V., Curran, Stephen M., Dyavar, Shetty Ravi, Arnold, Lora L., Cohen, Samuel M., Kumar, Devendra, Alnouti, Yazen, Coulter, Don W., Singh, Rakesh K., Vetro, Joseph A.

    Published in Nanomedicine (01-04-2021)
    “…RNA interference molecules have tremendous potential for cancer therapy but are limited by insufficient potency after i.v. administration. We previously found…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    The modification of siRNA with 3′ cholesterol to increase nuclease protection and suppression of native mRNA by select siRNA polyplexes by Ambardekar, Vishakha V, Han, Huai-Yun, Varney, Michelle L, Vinogradov, Serguei V, Singh, Rakesh K, Vetro, Joseph A

    Published in Biomaterials (01-02-2011)
    “…Abstract Polymer-siRNA complexes (siRNA polyplexes) are being actively developed to improve the therapeutic application of siRNA. A major limitation for many…”
    Get full text
    Journal Article
  12. 12

    Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cells by Haney, Matthew J, Zhao, Yuling, Li, Shu, Higginbotham, Sheila M, Booth, Stephanie L, Han, Huai-Yun, Vetro, Joseph A, Mosley, R Lee, Kabanov, Alexander V, Gendelman, Howard E, Batrakova, Elena V

    Published in Nanomedicine (London, England) (01-09-2011)
    “…Our laboratories forged the concept of macrophage delivery of protein antioxidants to attenuate neuroinflammation and nigrostriatal neurodegeneration in…”
    Get more information
    Journal Article
  13. 13

    The efficacy of nuclease-resistant Chol-siRNA in primary breast tumors following complexation with PLL-PEG(5K) by Ambardekar, Vishakha V, Wakaskar, Rajesh R, Sharma, Bhawna, Bowman, Joy, Vayaboury, Willy, Singh, Rakesh K, Vetro, Joseph A

    Published in Biomaterials (01-07-2013)
    “…Abstract Modifying the sense strand of nuclease-resistant siRNA with 3′-cholesterol (Chol-*siRNA) increases mRNA suppression after i.v. administration but with…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Effects of the PPARγ agonist troglitazone on endothelial cells in vivo and in vitro: Differences between human and mouse by Kakiuchi-Kiyota, Satoko, Vetro, Joseph A., Suzuki, Shugo, Varney, Michelle L., Han, Huai-Yun, Nascimento, Merielen, Pennington, Karen L., Arnold, Lora L., Singh, Rakesh K., Cohen, Samuel M.

    Published in Toxicology and applied pharmacology (15-05-2009)
    “…Peroxisome proliferator-activated receptor gamma (PPARγ) agonists and PPARγ/α dual agonists have been or are being developed for clinical use in the treatment…”
    Get full text
    Journal Article
  16. 16

    The Specificity in Vivo of Two Distinct Methionine Aminopeptidases in Saccharomyces cerevisiae by Chen, Shaoping, Vetro, Joseph A., Chang, Yie-Hwa

    Published in Archives of biochemistry and biophysics (01-02-2002)
    “…In Saccharomyces cerevisiae, the essential function of amino-terminal methionine removal is provided cotranslationally by two methionine aminopeptidases…”
    Get full text
    Journal Article
  17. 17

    Structure/function analysis of peptoid/lipitoid:DNA complexes by Lobo, Brian A, Vetro, Joseph A, Suich, Daniel M, Zuckermann, Ronald N, Middaugh, C Russell

    Published in Journal of pharmaceutical sciences (01-09-2003)
    “…Previous transfection studies of cationic peptoid polymers (N-substituted polyglycines) and cationic lipitoid polymers (peptoid-phospholipid conjugates) have…”
    Get more information
    Journal Article
  18. 18

    Evidence of a dominant negative mutant of yeast methionine aminopeptidase type 2 in Saccharomyces cerevisiae by Vetro, Joseph A., Dummitt, Benjamin, Micka, William S., Chang, Yie-Hwa

    Published in Journal of cellular biochemistry (01-03-2005)
    “…Eukaryotic methionine aminopeptidase type 2 (MetAP2, MetAP2 gene (MAP2)), together with eukaryotic MetAP1, cotranslationally hydrolyzes initiator methionine…”
    Get full text
    Journal Article
  19. 19

    Musocal vaccine for universal influenza A protection by Phillips, Joy A, Tallapaka, Shailendra B, Vetro, Joseph A, Sanderson, Sam D, Thoman, Marilyn L

    Published in The Journal of immunology (1950) (01-05-2016)
    “…The rapid mutation rate of the influenza virus requires that the yearly flu vaccine development cycle start months in advance of the flu season. The search for…”
    Get full text
    Journal Article
  20. 20

    The modification of siRNA with 3a super(2) cholesterol to increase nuclease protection and suppression of native mRNA by select siRNA polyplexes by Ambardekar, Vishakha V, Han, Huai-Yun, Varney, Michelle L, Vinogradov, Serguei V, Singh, Rakesh K, Vetro, Joseph A

    Published in Biomaterials (01-02-2011)
    “…Polymer-siRNA complexes (siRNA polyplexes) are being actively developed to improve the therapeutic application of siRNA. A major limitation for many siRNA…”
    Get full text
    Journal Article